Skip to content

Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00727883
Acronym
SOSTA
Enrollment
190
Registered
2008-08-04
Start date
2007-07-31
Completion date
2008-05-31
Last updated
2010-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast Cancer, Adjuvant TAM, post-menopausal, women

Brief summary

Retrospective observational trial on reasons for withdraw of Adjuvant Tamoxifen in Breast Cancer patients

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Breast Ca Patients with surgery and withdraw of adjuvant treatment with Tamoxifen for Tam related AEs * Documented reasons for treatment withdrawal

Exclusion criteria

* enrollment in other studies * treatment withdraw for other causes than Tam related AEs

Design outcomes

Primary

MeasureTime frame
incidence of withdraw from adjuvant Tamoxifen due to Tam related AEsJanuary 2003-December 2004

Secondary

MeasureTime frame
Types of TAM related AEJanuary 2003-December 2004

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026